Literature DB >> 22592746

Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

William J Taylor1.   

Abstract

Psoriatic arthritis is associated with a broad range of problems from the perspective of the patient. These include symptoms relating to skin and musculoskeletal disease to difficulties with day-to-day activities, social interactions, paid employment, and community participation. Additional problems related to frequent comorbidities impose further impact. It has been shown that individuals with psoriatic arthritis have similar or worse disability than men older than 75 years of age in the general population, and psoriatic arthritis confers worse health status than many other common chronic diseases. The World Health Organization International Classification of Functioning, Disability, and Health provides a useful framework for considering the impact of this disease. Ideal clinical management of psoriatic arthritis would provide access to an interdisciplinary team with expertise in functional, social, vocational, and community issues, as well as to medical expertise.

Entities:  

Mesh:

Year:  2012        PMID: 22592746     DOI: 10.1007/s11926-012-0263-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  19 in total

1.  Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis.

Authors:  Ying Ying Leung; Kwok Wah Ho; Tracy Y Zhu; Lai Shan Tam; Emily Wai-Lin Kun; Edmund Kwok-Ming Li
Journal:  Rheumatology (Oxford)       Date:  2010-04-25       Impact factor: 7.580

2.  Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

Authors:  Angela Zink; Katja Thiele; Doerte Huscher; Joachim Listing; Joachim Sieper; Andreas Krause; Erika Gromnica-Ihle; Ulrich von Hinueber; Siegfried Wassenberg; Ekkehard Genth; Matthias Schneider
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

3.  Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

Authors:  J A Husted; D D Gladman; V T Farewell; R J Cook
Journal:  Arthritis Rheum       Date:  2001-04

4.  A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis.

Authors:  Pinar Borman; Guneş Gur Toy; Seçil Babaoğlu; Hatice Bodur; Deniz Ciliz; Nuran Alli
Journal:  Clin Rheumatol       Date:  2006-04-19       Impact factor: 2.980

5.  Patient-reported outcomes for arthritis: time to focus on personal life impact measures?

Authors:  Tessa Sanderson; John Kirwan
Journal:  Arthritis Rheum       Date:  2009-01-15

6.  Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity.

Authors:  L Lundberg; M Johannesson; M Silverdahl; C Hermansson; M Lindberg
Journal:  Acta Derm Venereol       Date:  2000 Nov-Dec       Impact factor: 4.437

7.  Marked by visibility of psoriasis in everyday life.

Authors:  Margaretha Uttjek; Lennart Nygren; Berndt Stenberg; Mona Dufåker
Journal:  Qual Health Res       Date:  2007-03

8.  Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey.

Authors:  David H Ciocon; Elizabeth J Horn; Alexa B Kimball
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

9.  The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.

Authors:  E Christophers; J N W N Barker; C E M Griffiths; E Daudén; G Milligan; C Molta; R Sato; R Boggs
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-10-23       Impact factor: 6.166

10.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

View more
  8 in total

1.  Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health.

Authors:  Kate Carter; Caterina Tannous; Steven Walmsley; Keith Rome; Deborah E Turner
Journal:  Rheumatol Adv Pract       Date:  2020-07-11

2.  A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.

Authors:  David Pariser; Brad Schenkel; Chureen Carter; Kamyar Farahi; T Michelle Brown; Charles N Ellis
Journal:  J Dermatolog Treat       Date:  2015-07-03       Impact factor: 3.359

3.  The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study.

Authors:  Annelie Bilberg; Ingrid Larsson; Sofia Björkman; Björn Eliasson; Eva Klingberg
Journal:  Clin Rheumatol       Date:  2022-06-01       Impact factor: 3.650

4.  Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis.

Authors:  Anastasiya Muntyanu; Fatima Abji; Kun Liang; Remy A Pollock; Vinod Chandran; Dafna D Gladman
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156

5.  Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison.

Authors:  Vibeke Strand; Keith A Betts; Manish Mittal; Jinlin Song; Martha Skup; Avani Joshi
Journal:  Rheumatol Ther       Date:  2017-07-31

6.  Preliminary development of a questionnaire assessing the impact of psoriasis and psoriatic arthritis on patient's perception of sexuality.

Authors:  Eric Esteve; François Maccari; Dominique Delavierre; Catherine Vicariot; Bénédicte Charles; Marc Marty; Eric Lespessailles
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis.

Authors:  Yan Song; Keith A Betts; Yichen Lu; Rakesh Singh; Jerry Clewell; Jenny Griffith
Journal:  Rheumatol Ther       Date:  2019-05-04

8.  Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis-A Retrospective Database Study.

Authors:  Philipp Sewerin; Kathrin Borchert; Dominic Meise; Matthias Schneider; Jörg Mahlich
Journal:  Rheumatol Ther       Date:  2021-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.